IDEX (NYSE:IEX - Get Free Report) had its price objective hoisted by Stifel Nicolaus from $267.00 to $273.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a "buy" rating on the industrial products company's stock. Stifel Nicolaus's target price suggests a potential upside of 14.12% from the stock's current price.
A number of other brokerages have also recently weighed in on IEX. Robert W. Baird set a $268.00 target price on IDEX in a report on Thursday. Citigroup restated a "buy" rating on shares of IDEX in a research note on Thursday. Argus upped their price target on IDEX from $250.00 to $260.00 and gave the stock a "buy" rating in a research note on Thursday, August 6th. KeyCorp upgraded IDEX to a "hold" rating in a report on Monday, October 12th. Finally, Royal Bank Of Canada lifted their price objective on IDEX from $280.00 to $285.00 and gave the company an "outperform" rating in a research note on Wednesday, October 14th. Nine analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $262.64.
Read Our Latest Stock Report on IDEX
IDEX Stock Up 2.6%
Shares of IEX opened at $239.22 on Thursday. IDEX has a fifty-two week low of $160.60 and a fifty-two week high of $243.80. The company's fifty day moving average is $230.00 and its two-hundred day moving average is $215.45. The firm has a market cap of $17.64 billion, a PE ratio of 34.42, a price-to-earnings-growth ratio of 2.60 and a beta of 0.97. The company has a quick ratio of 2.15, a current ratio of 3.05 and a debt-to-equity ratio of 0.46.
IDEX (NYSE:IEX - Get Free Report) last released its quarterly earnings data on Wednesday, October 28th. The industrial products company reported $2.33 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.09. The business had revenue of $951.70 million during the quarter, compared to the consensus estimate of $934.36 million. IDEX had a return on equity of 15.69% and a net margin of 14.49%. The business's revenue for the quarter was up 8.3% on a year-over-year basis. During the same period in the prior year, the firm posted $2.03 EPS. Analysts forecast that IDEX will post 8.83 earnings per share for the current year.
Insider Buying and Selling
In other IDEX news, CAO Lisa Anderson sold 385 shares of the business's stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $238.59, for a total transaction of $91,857.15. Following the transaction, the chief accounting officer owned 4,327 shares in the company, valued at $1,032,378.93. The trade was a 8.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.50% of the stock is owned by company insiders.
Institutional Investors Weigh In On IDEX
Several institutional investors and hedge funds have recently modified their holdings of IEX. BlackRock Inc. purchased a new stake in shares of IDEX during the 2nd quarter valued at about $1,301,393,000. Primecap Management Co. CA acquired a new stake in IDEX in the second quarter valued at approximately $748,951,000. Amundi grew its position in IDEX by 19.6% in the second quarter. Amundi now owns 1,458,979 shares of the industrial products company's stock valued at $331,017,000 after acquiring an additional 239,579 shares in the last quarter. Bank of America Corp DE grew its position in IDEX by 215.0% in the first quarter. Bank of America Corp DE now owns 1,094,101 shares of the industrial products company's stock valued at $207,387,000 after acquiring an additional 746,732 shares in the last quarter. Finally, Alyeska Investment Group L.P. raised its stake in shares of IDEX by 101.4% during the second quarter. Alyeska Investment Group L.P. now owns 1,042,703 shares of the industrial products company's stock valued at $236,641,000 after purchasing an additional 525,048 shares during the period. Hedge funds and other institutional investors own 97.96% of the company's stock.
Key Stories Impacting IDEX
Here are the key news stories impacting IDEX this week:
- Positive Sentiment: Q3 earnings and revenue exceeded expectations. IDEX reported $951.7 million in sales, up 8.3% year over year and ahead of the $934.4 million consensus estimate. Adjusted earnings of $2.33 per share surpassed expectations of approximately $2.24 and increased from $2.03 a year earlier. IDEX Q3 Earnings and Revenues Beat Estimates
- Positive Sentiment: Management raised its 2026 outlook. IDEX now expects 6.5%–6.8% organic sales growth and adjusted diluted EPS of $8.91–$8.96, citing continued momentum in advantaged markets. IDEX Forecasts Organic Growth and Adjusted EPS
- Positive Sentiment: Orders and key businesses showed broad strength. Third-quarter orders rose 13% to $991.2 million. Health & Science Technologies sales climbed 14%, while Fluid & Metering Technologies and Fire & Safety/Diversified Products grew 3% and 5%, respectively. Operating cash flow also increased to $239.5 million. IDEX Posts Record Third-Quarter Sales
- Positive Sentiment: Capital returns supported the investment case. IDEX returned $129 million to shareholders through dividends and share repurchases during the quarter. One valuation analysis also estimated the shares could be about 7% undervalued following the earnings update. IDEX Could Be 7% Undervalued
- Neutral Sentiment: Valuation remains a consideration. The stock trades near its 52-week high at roughly 34 times earnings, with a PEG ratio of 2.6, meaning further gains may depend on the company sustaining its upgraded growth outlook.
- Negative Sentiment: Recent insider activity was entirely selling. Reported transactions over the past six months included sales by the CEO and a senior executive, with no disclosed insider purchases. This is a secondary cautionary signal rather than a change to the company’s operating outlook.
IDEX Company Profile
(
Get Free Report)
IDEX Corporation is an industrial manufacturing company headquartered in Lake Forest, Illinois. The company designs and produces engineered products and technologies used to move, control, measure and apply fluids, as well as equipment used in fire and safety applications.
IDEX operates through businesses serving fluid and metering technologies, health and science technologies, and fire and safety markets. Its products include pumps, valves, flow meters, compressors, dispensing equipment, precision fluidics components and systems, fire pumps, rescue tools and other specialized equipment.
The company serves a broad range of industries, including healthcare, life sciences, water and wastewater, chemical processing, energy, food and beverage, agriculture, industrial manufacturing and municipal fire protection.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider IDEX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IDEX wasn't on the list.
While IDEX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.